Topotecan in Treating Children With Refractory Leukemia

NCT00002705 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Leukemia

Interventions

DRUG: topotecan hydrochloride

Sponsor

National Cancer Institute (NCI)